| Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease CP Jacob, E Koutsilieri, J Bartl, E Neuen-Jacob, T Arzberger, N Zander, ... Journal of Alzheimer's disease 11 (1), 97-116, 2007 | 356 | 2007 |
| Aberrant ERBB4-SRC signaling as a hallmark of group 4 medulloblastoma revealed by integrative phosphoproteomic profiling A Forget, L Martignetti, S Puget, L Calzone, S Brabetz, D Picard, ... Cancer cell 34 (3), 379-395. e7, 2018 | 158 | 2018 |
| Gene expression as peripheral biomarkers for sporadic Alzheimer's disease E Grünblatt, J Bartl, S Zehetmayer, TM Ringel, P Bauer, P Riederer, ... Journal of Alzheimer's Disease 16 (3), 627-634, 2009 | 77 | 2009 |
| Genetic risk factors and markers for Alzheimer’s disease and/or depression in the VITA study E Grünblatt, S Zehetmayer, J Bartl, C Löffler, I Wichart, MK Rainer, ... Journal of psychiatric research 43 (3), 298-308, 2009 | 75 | 2009 |
| The link between iron, metabolic syndrome, and Alzheimer’s disease E Grünblatt, J Bartl, P Riederer Journal of Neural Transmission 118, 371-379, 2011 | 73 | 2011 |
| Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease E Grünblatt, N Zander, J Bartl, L Jie, CM Monoranu, T Arzberger, R Ravid, ... Journal of Alzheimer's Disease 12 (4), 291-311, 2007 | 69 | 2007 |
| Diabetes type II: A risk factor for depression–Parkinson–Alzheimer? P Riederer, J Bartl, G Laux, E Grünblatt Neurotoxicity research 19, 253-265, 2011 | 67 | 2011 |
| Neuron-specific alterations in signal transduction pathways associated with Alzheimer's disease A Gerschütz, H Heinsen, E Grünblatt, AK Wagner, J Bartl, C Meissner, ... Journal of Alzheimer's Disease 40 (1), 135-142, 2014 | 62* | 2014 |
| The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma U Ahmadov, D Picard, J Bartl, M Silginer, M Trajkovic-Arsic, N Qin, ... Cell death & disease 12 (10), 885, 2021 | 46 | 2021 |
| Effects of methylphenidate: the cellular point of view J Bartl, P Link, C Schlosser, M Gerlach, A Schmitt, S Walitza, P Riederer, ... ADHD Attention Deficit and Hyperactivity Disorders 2, 225-232, 2010 | 44 | 2010 |
| Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction E Grünblatt, J Bartl, DI Iuhos, A Knezovic, V Trkulja, P Riederer, S Walitza, ... Journal of molecular psychiatry 3, 1-10, 2015 | 37 | 2015 |
| Methylphenidate enhances neuronal differentiation and reduces proliferation concomitant to activation of Wnt signal transduction pathways E Grünblatt, J Bartl, S Walitza Translational psychiatry 8 (1), 51, 2018 | 33 | 2018 |
| Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity J Bartl, T Müller, E Grünblatt, M Gerlach, P Riederer Journal of Neural Transmission 121, 379-383, 2014 | 33 | 2014 |
| Further evidence for plasma progranulin as a biomarker in bipolar disorder S Kittel-Schneider, J Weigl, J Volkert, A Geßner, B Schmidt, S Hempel, ... Journal of affective disorders 157, 87-91, 2014 | 30 | 2014 |
| Alzheimer's disease and type 2 diabetes: two diseases, one common link? J Bartl, CM Monoranu, AK Wagner, J Kolter, P Riederer, E Grünblatt The World Journal of Biological Psychiatry 14 (3), 233-240, 2013 | 27 | 2013 |
| Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to … V Marquardt, J Theruvath, D Pauck, D Picard, N Qin, L Blümel, M Maue, ... Journal for ImmunoTherapy of Cancer 11 (1), 2023 | 26 | 2023 |
| Methyl-and acetyltransferases are stable epigenetic markers postmortem CM Monoranu, E Grünblatt, J Bartl, A Meyer, M Apfelbacher, D Keller, ... Cell and tissue banking 12, 289-297, 2011 | 26 | 2011 |
| Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzymegene J Bartl, CJ Scholz, M Hinterberger, S Jungwirth, I Wichart, MK Rainer, ... BMC medical genetics 12, 1-8, 2011 | 23 | 2011 |
| The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitro J Bartl, F Palazzesi, M Parrinello, L Hommers, P Riederer, S Walitza, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 79, 281-288, 2017 | 22 | 2017 |
| Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways J Bartl, A Meyer, S Brendler, P Riederer, E Grünblatt Journal of Neural Transmission 120, 113-120, 2013 | 22 | 2013 |
